We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Reverse Innovation in Western Health Care: the ReMotion Prosthetic Knee.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04700085
Recruitment Status : Completed
First Posted : January 7, 2021
Last Update Posted : January 7, 2021
Sponsor:
Information provided by (Responsible Party):
Sint Maartenskliniek

Brief Summary:
Ambulatory mobility and function are important aspects in the quality of life of people with lower limb amputations and prostheses. Regaining mobility is often challenging, especially for patients with transfemoral, or above-knee, amputations. In the past decades, new types of knee prosthetics have entered the market. The standard care in Europe and the US at this moment is the mechanical, or non-microprocessor controlled, knee (NMPK). While the production costs of these NMPK's are lower than those of the MPK's (microprocessor controlled knee), consumer prices still reach up to $5000. Recently, the ReMotion Knee ($80) was developed as a new and affordable alternative to the currently available mechanical knees. The ReMotion Knee is mostly used in low-income countries, but has now been approved according to the ISO 10328 standards and has received the CE Mark. This knee could be a more affordable alternative for the prosthetic knees used in high-income countries, thereby decreasing health related costs within the amputation population. However, research on patient's functional abilities and personal experiences with the knee is very limited and has not been investigated within more developed countries. Therefore, the objective of this study is to compare the ReMotion Knee and the current prosthetic knee of patients with a transfemoral amputation or knee-exarticulation in terms of functional mobility, balance, and experienced walking comfort, balance trust, fatigue and performance of the knee. it is expected that the ReMotion Knee will perform slightly worse than the participants' current prosthetic knees.

Condition or disease Intervention/treatment Phase
Lower Limb Amputation Above Knee (Injury) Lower Limb Amputation Knee Device: ReMotion Knee Not Applicable

Detailed Description:

The primary aim of healthcare organizations is to optimize the quality of life of their patients while keeping a good balance between quality and costs. More advanced medical technologies are constantly being developed to improve quality of life. However, these technologies also lead to rising healthcare costs in high-income countries. Cost pressures from medical innovations, along with the ageing population form a substantial threat to the long-term sustainability of healthcare systems in high-income countries. Reverse innovations (products or ideas originally designed for use in low-income countries that are 'upgraded' and implemented in high-income countries) provide an opportunity to restrain the rising healthcare costs in high-income countries. These products are often low-priced, easy to use, and designed to function and survive in extreme and unpredictable conditions. However, low-income country of origin products are still generally perceived as less reliable and safe and they are rarely researched as an alternative to the current standard of care within the medical sector.

The field of lower limb prosthetics is a typical example of a medical field with unceasing technological developments, accompanied by rising expenses. With the rising incidence of lower-limb amputations and the rising prosthetic prices, the costs of prosthetics care will keep increasing. Reverse innovation could play an essential role in controlling the costs of prosthetic care in the upcoming decades. However, research on new, lower-priced alternative prostheses for use in high-income countries is very scarce and deserves more attention. An example of a potential reverse innovation for the prosthetics market is the ReMotion knee: an $80 mechanical knee recently designed by D-Rev (San Francisco, CA, USA) for use in low-income countries. The ReMotion Knee has a polycentric design and a lifespan of about 3-5 years, comparable to other mechanical knees, but does not include a pneumatic or hydraulic system. It is easy to use, provides patients with a basic functional mobility, and is low priced, especially compared to the standard care mechanical knees ranging between $1000 and $4000 in the Netherlands. The ReMotion Knee could in this new way propose an opportunity to greatly reduce healthcare costs among amputees in high-income countries. So far there is no research available on health outcomes with the ReMotion Knee other than overall user satisfaction, and it has never been evaluated as an alternative prosthetic knee for use in high-income countries.

This study aims to evaluate the ReMotion Knee as a potential reverse innovation and provide insight in the value of reverse innovation. To this end, the ReMotion Knee was compared with currently used and comparable mechanical prosthetics knees in high-income countries. The knees were evaluated based on the most important health outcomes for people with a lower-limb amputation: functional mobility, walking comfort, balance and trust in balance. Furthermore, experienced fatigue and performance with the knees were examined. As the ReMotion Knee has less features advanced features than most polycentric prosthetic knees currently used, it was expected that all would be slightly lower with the ReMotion Knee.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 9 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Intervention Model Description: Randomized crossover trial design
Masking: None (Open Label)
Masking Description: Participants and researcher could not be blinded as participants performed a training session with the ReMotion Knee (one of the conditions) and the prosthetic knee type was visible to both.
Primary Purpose: Supportive Care
Official Title: Reverse Innovation in Western Health Care: the ReMotion Prosthetic Knee.
Actual Study Start Date : February 27, 2019
Actual Primary Completion Date : August 7, 2019
Actual Study Completion Date : August 7, 2019

Arm Intervention/treatment
Experimental: ReMotion Knee
The ReMotion Knee (mechanical prosthetic knee type) was used during measurements
Device: ReMotion Knee
The ReMotion Knee is a prosthetic knee mostly used in low-income countries. It has been approved according to the ISO 10328 standards and has received the CE Mark.

No Intervention: Current prosthetic knee
The participant's current prosthetic knee was used during measurements



Primary Outcome Measures :
  1. L-test [ Time Frame: 5 minutes ]
    Measure for functional mobility


Secondary Outcome Measures :
  1. Four Square Step Test (FSST) [ Time Frame: 5 minutes ]
    Measure for presicion stepping

  2. Berg Balance Scale (BBS) [ Time Frame: 15 minutes ]
    Measure for static balance

  3. Weight distribution during static stance [ Time Frame: 2 minutes ]
    Measure for static balance

  4. Modified Emory Functional Amputation Profile (mEFAP) [ Time Frame: 5 minutes ]
    Measure for functional mobility

  5. Experienced walking comfort [ Time Frame: On average, after 30 minutes and after 90 minutes ]
    Experienced walking comfort is measured with a visual analog scale (VAS) of 10 centimeters (lowest score is 0, highest score is 10).

  6. Experienced trust in balance [ Time Frame: On average, after 30 minutes and after 90 minutes ]
    Experienced trust in balance is measured with a visual analog scale (VAS) of 10 centimeters (lowest score is 0, highest score is 10).

  7. Experienced performance of the knee [ Time Frame: On average, after 30 minutes and after 90 minutes ]
    Experienced performance of the knee is measured with a visual analog scale (VAS) of 10 centimeters (lowest score is 0, highest score is 10).

  8. Experienced fatigue [ Time Frame: On average, after 30 minutes and after 90 minutes ]
    Experienced fatigue is measured with a visual analog scale (VAS) of 10 centimeters (lowest score is 0, highest score is 10).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Medicare Functional Classification Level (MFCL) 2 or 3 (most probable users of the ReMotion Knee)
  • at least one year since amputation
  • currently using a polycentric mechanical prosthetic knee.

Exclusion Criteria:

  • stump pain that increases with activity
  • a hip flexion contracture > 20 degrees
  • inability to stand and walk for thirty minutes
  • weight >80kg (weight limit of the ReMotion Knee)
  • a prosthetic socket connection that did not fit the ReMotion Knee
  • an osseointegrated prosthesis

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04700085


Locations
Layout table for location information
Netherlands
Sint Maartenskliniek
Ubbergen, Gelderland, Netherlands, 6574NA
Sponsors and Collaborators
Sint Maartenskliniek
Investigators
Layout table for investigator information
Study Chair: Noël LW Keijsers, PhD Sint Maartenskliniek
Layout table for additonal information
Responsible Party: Sint Maartenskliniek
ClinicalTrials.gov Identifier: NCT04700085    
Other Study ID Numbers: 837_ReMotion_Knee
First Posted: January 7, 2021    Key Record Dates
Last Update Posted: January 7, 2021
Last Verified: January 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No